WebMay 4, 2024 · MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 4, 2024-- NeuroPace, Inc.a medical technology company dedicated to transforming the lives of people suffering from epilepsy, today announced that the first patient was treated in the RESPONSE clinical trial, which will evaluate the safety and effectiveness of the RNS®System in adolescent … WebMartha J. Morrell. Age : 65. Public asset : 703,651 USD. Linked companies : NeuroPace, Inc. Summary. Martha J. Morrell occupies the position of Chief Medical Officer at NeuroPace, Inc. Dr. Morrell is also on the board of American Epilepsy Society and Clinical Professor at Stanford University. She previously occupied the position of Chairman at ...
Dr. Martha J. Morrell, MD Palo Alto, CA - US News Health
WebMedical Equipment Manufacturing Company size 51-200 employees Headquarters Mountain View, CA Type Public Company Founded 1999 Locations Primary 455 N. … WebDr. Morrell became Chief Medical Officer of NeuroPace, Inc. in July 2004, as well as a Clinical Professor of Neurology at Stanford University. Before joining NeuroPace, she … etsy albert thurston
First Patient Treated in Adolescent Epilepsy Trial Assessing NeuroPace ...
WebBased in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or … WebApr 9, 2024 · Dr. Morrell has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with NeuroPace, Inc. Dr. Morrell holds stock and/or stock options in NeuroPace, Inc, which sponsored research in which Dr. Morrell was involved as an investigator. Dr. WebApr 22, 2024 · Mountain View epilepsy device maker NeuroPace's stock jumps 47% in debut Enlarge NeuroPace executives posed in front of at Nasdaq in New York on Thursday to mark the company's IPO. Shown here... firewall-cmd nat port forwarding